United States · FDA National Drug Code directory
BEIZRAY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-2093_4efe8f3a-a176-4b69-90c8-5ba5891dccfd
- Product NDC
- 70710-2093
- Form
- KIT
- Composition / generic term
- docetaxel
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250828
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 KIT (70710-2093-4) * 4 mL in 1 VIAL, GLASS (70710-2090-1) * 50 mL in 1 VIAL, GLASS (64208-2512-4) * 4 mL in 1 VIAL, GLASS (70710-2090-1) · 70710-2093-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →